Medco Health Solutions Inc. (MHS) announced the acquisition of DNA Direct Inc. Financial details of the acquisition were not released.
DNA Direct provides guidance and decision support for genomic medicine to patients, providers, payors and employees. DNA Direct is the first genomics-focused company offering URAC-accredited utilization management programs to help payors ensure the appropriate use of the more than 2,000 genetic and molecular tests available today. The company is based in San Francisco and was backed by Firefly Investments and Lemhi Ventures.
DNA Direct's national call center of genetic experts, complemented by online decision support services help physicians and patients determine if genetic tests are appropriate and how to use genetic test results to guide clinical decisions.
For comments and feedback: editorial@rttnews.com